• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为微管结构和功能遗传探针的抗有丝分裂剂抗性

Resistance to antimitotic agents as genetic probes of microtubule structure and function.

作者信息

Cabral F, Barlow S B

机构信息

Department of Pharmacology, University of Texas Medical School, Houston 77225.

出版信息

Pharmacol Ther. 1991 Nov;52(2):159-71. doi: 10.1016/0163-7258(91)90006-8.

DOI:10.1016/0163-7258(91)90006-8
PMID:1818334
Abstract

Much of our knowledge about microtubules has come from detailed morphological, biochemical, and cell biological studies. As more is learned about these organelles, questions regarding the in vivo regulation of their expression and function become increasingly important. Genetics provides an approach to address these more subtle questions in the living cell. Mammalian mutants with microtubule alterations have been isolated using selections for resistance to the cytotoxic effects of a number of antimitotic drugs. A subset of these mutants have clearly defined alterations in alpha- or in beta-tubulin, and these have been used to explore the mechanisms by which mammalian cells acquire resistance to this class of drugs. In addition, the mutants are providing valuable insights into how tubulin expression is regulated, into what factors determine the extent of microtubule assembly in living cells, into the domains of tubulin that are involved in assembly, and into the role of microtubules in essential cellular processes.

摘要

我们对微管的许多了解都来自详细的形态学、生物化学和细胞生物学研究。随着对这些细胞器的了解越来越多,关于其体内表达和功能调控的问题变得越来越重要。遗传学提供了一种在活细胞中解决这些更细微问题的方法。利用对多种抗有丝分裂药物细胞毒性作用的抗性筛选,已分离出具有微管改变的哺乳动物突变体。这些突变体的一个子集在α-或β-微管蛋白中具有明确界定的改变,并且这些已被用于探索哺乳动物细胞获得对这类药物抗性的机制。此外,这些突变体为微管蛋白表达如何被调控、哪些因素决定活细胞中微管组装的程度、参与组装的微管蛋白结构域以及微管在基本细胞过程中的作用提供了有价值的见解。

相似文献

1
Resistance to antimitotic agents as genetic probes of microtubule structure and function.作为微管结构和功能遗传探针的抗有丝分裂剂抗性
Pharmacol Ther. 1991 Nov;52(2):159-71. doi: 10.1016/0163-7258(91)90006-8.
2
The colR4 and colR15 beta-tubulin mutations in Chlamydomonas reinhardtii confer altered sensitivities to microtubule inhibitors and herbicides by enhancing microtubule stability.莱茵衣藻中的colR4和colR15β-微管蛋白突变通过增强微管稳定性赋予对微管抑制剂和除草剂的敏感性改变。
J Cell Biol. 1991 May;113(3):605-14. doi: 10.1083/jcb.113.3.605.
3
Mechanism of action of antimitotic drugs: a new hypothesis based on the role of cellular calcium.抗有丝分裂药物的作用机制:基于细胞钙作用的新假说
Med Hypotheses. 1989 Jan;28(1):57-69. doi: 10.1016/0306-9877(89)90154-0.
4
Natural organic compounds that affect to microtubule functions.影响微管功能的天然有机化合物。
Yakugaku Zasshi. 1998 Apr;118(4):112-26.
5
Microtubule S-glutathionylation as a potential approach for antimitotic agents.微管 S-谷胱甘肽化作为一种潜在的抗有丝分裂药物作用机制。
BMC Cancer. 2012 Jun 15;12:245. doi: 10.1186/1471-2407-12-245.
6
[Antimitotic agents].[抗有丝分裂剂]
Gan To Kagaku Ryoho. 1997 Sep;24(11):1519-25.
7
Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly.
FASEB J. 1989 Mar;3(5):1593-9. doi: 10.1096/fasebj.3.5.2646163.
8
Structural insight into microtubule function.对微管功能的结构洞察。
Annu Rev Biophys Biomol Struct. 2001;30:397-420. doi: 10.1146/annurev.biophys.30.1.397.
9
Physiochemical aspects of tubulin-interacting antimitotic drugs.微管蛋白相互作用抗有丝分裂药物的物理化学特性
Curr Pharm Des. 2001 Sep;7(13):1213-28. doi: 10.2174/1381612013397438.
10
Structural insights into microtubule function.对微管功能的结构见解。
Annu Rev Biochem. 2000;69:277-302. doi: 10.1146/annurev.biochem.69.1.277.

引用本文的文献

1
Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.β-微管蛋白的随机诱变定义了一组分散的突变,这些突变赋予紫杉醇抗性。
Pharm Res. 2012 Nov;29(11):2994-3006. doi: 10.1007/s11095-012-0794-5. Epub 2012 Jun 6.
2
Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance.有丝分裂着丝粒相关驱动蛋白(MCAK)介导紫杉醇耐药性。
J Biol Chem. 2011 Oct 21;286(42):36378-84. doi: 10.1074/jbc.M111.296483. Epub 2011 Sep 7.
3
Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell division.
巨核细胞谱系特异性的 6 类β-微管蛋白抑制微管动力学,使微管片段化,并阻止细胞分裂。
Cytoskeleton (Hoboken). 2011 Mar;68(3):175-87. doi: 10.1002/cm.20503.
4
Class V β-tubulin alters dynamic instability and stimulates microtubule detachment from centrosomes.V 类 β-微管蛋白改变动态不稳定性并刺激微管从中心体上脱离。
Mol Biol Cell. 2011 Apr;22(7):1025-34. doi: 10.1091/mbc.E10-10-0822. Epub 2011 Feb 2.
5
Paclitaxel-dependent cell lines reveal a novel drug activity.紫杉醇依赖性细胞系揭示了一种新的药物活性。
Mol Cancer Ther. 2010 Nov;9(11):2914-23. doi: 10.1158/1535-7163.MCT-10-0552. Epub 2010 Oct 26.
6
Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.细胞迁移和细胞分裂的抑制与微管抑制药物的独特作用相关。
J Biol Chem. 2010 Oct 15;285(42):32242-50. doi: 10.1074/jbc.M110.160820. Epub 2010 Aug 9.
7
Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.V 类β-微管蛋白对微管组装和紫杉醇耐药性影响的分子基础。
J Biol Chem. 2009 May 8;284(19):13023-32. doi: 10.1074/jbc.M900167200. Epub 2009 Mar 12.
8
New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones.化疗耐药转移性乳腺癌的新治疗选择:埃坡霉素类药物
Drugs. 2008;68(2):139-46. doi: 10.2165/00003495-200868020-00001.
9
A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.一种普遍存在的β微管蛋白会破坏微管组装并抑制细胞增殖。
Mol Biol Cell. 2004 Jul;15(7):3123-31. doi: 10.1091/mbc.e04-01-0060. Epub 2004 Apr 30.
10
Beta class II tubulin predominates in normal and tumor breast tissues.βII类微管蛋白在正常和肿瘤乳腺组织中占主导地位。
Breast Cancer Res. 2003;5(5):R157-69. doi: 10.1186/bcr631. Epub 2003 Jul 28.